Associations Between Measurement RV, RV/TLC, and FRC/TLC with Clinical Symptoms in COPD Patients in Persahabatan Hospital
DOI:
https://doi.org/10.36497/jri.v43i4.571Keywords:
COPD, FRC/TLC, Residual volume (RV), RV/TLCAbstract
Background: This preliminary study to measure lung volume in patients with stable COPD in Persahabatan Central General Hospital Jakarta to determine the prevalence of the increasing value of lung volume in patients with stable COPD.
Methods: This study used a cross-sectional study design of outpatients with stable COPD who visited the asthma-COPD clinic at Persahabatan Central General Hospital Jakarta. The Lung volume test using a gas dilution Multiple Breath Nitrogen Washout (MBNW) was taken consecutively from February to March 2016.
Results: Tests of spirometry and Lung volumes were performed on 35 subjects. There were 3 subjects (8.6%) in COPD Group A, 9 subjects (25.7%) in COPD Group B, 9 subjects (25.7%) in COPD Group C, and 14 subjects (40%) in COPD Group D. At the age of 60 years, there were subjects (25.7%) and 60 years, 26 subjects (74.6%). Value Residual Volume/Total Lung Capacity (RV/TLC) has a significant relationship with the symptoms and a 6-minute walking test; however, Functional Residual Capacity/Total Lung Capacity (FRC/TLC) is significantly associated with the symptoms, a 6-minute walking test, and exacerbations within one year.
Conclusion: Value RV/TLC has a significant relationship with the symptoms and a 6-minute walking test; however, FRC/TLC is significantly associated with the symptoms, a 6-minute walking test, and exacerbations within one year.
Downloads
References
Global Initiative for Chronic Obstructive Lung (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2014.
Perhimpunan Dokter Paru Indonesia (PDPI). Definisi, permasalahan di Indonesia. In: Penyakit Paru Obstruktif Kronik (PPOK) Diagnosis dan Penatalaksanaan. Jakarta; 2011. p. 1–4.
Hogg JC, Saetta M. Pathology. In: Chronic obstructive pulmonary disease. 2nd ed. London: CRC Press; 2003. p. 11–20.
Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI. Pathologic features of chronic obstructive pulmonary diseases: Diagnostic criteria and differential diagnosis. In: Fishman’s Pulmonary Diseases and Disorders, Fourth Edition. 4th ed. New York: McGraw Hill Professional; 2008. p. 693–704.
Talag A Al, Wilcox P. Clinical physiology of chronic obstructive pulmonary disease. B C Med J. 2008;50(2):97–102.
Dykstra BJ, Scanion PD, Rester MM, Beck KC, Enright PL. Lung volumes in 4,774 patients with obstructive lung disease. Chest. 1999;115(1):68–74.
Efriadi. Hubungan antara hasil pemeriksaan kapasitas difusi paru terhadap karbonmonoksida (DLCO) metode napas tunggal dengan derajat pasien PPOK di RSUP Persahabatan Jakarta. [Jakarta]: Universitas Indonesia; 2015.
Travers J, Laveneziana P, Webb KA, Kesten S, O’Donnell DE. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med. 2007;101(9):2017–24.
O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–7.
Snoeck-Stroband JB, Lapperre TS, Gosman MME, Boezen HM, Timens W, Ten Hacken NHT, et al. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J. 2008;31(1):70–7.
Hartman JE, Ten Hacken NHT, Klooster K, Boezen HM, De Greef MHG, Slebos DJ. The minimal important difference for residual volume in patients with severe emphysema. Eur Respir J. 2012;40(5):1137–41.
Balcells E, Gea J, Ferrer J, Serra I, Orozco-Levi M, de Batlle J, et al. Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes. 2010;8:108.
Nizet TAC, Van Den Elshout FJJ, Heijdra YF, Van De Ven MJT, Mulder PGH, Folgering HTM. Survival of chronic hypercapnic COPD patients is predicted by smoking habits, comorbidity, and hypoxemia. Chest. 2005;127(6):1904–10.
Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100(10):1742–52.
Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med. 2010;104(2):275–82.
Parker CM, Voduc N, Aaron SD, Webb KA, O’Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26(3):420–8.
Gompertz S, Bayley DL, Hill SL, Stockley RA. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax. 2001;56(1):36–41.
Shin TR, Oh YM, Park JH, Lee KS, Oh S, Kang DR, et al. The prognostic value of Residual volume/total lung capacity in patients with chronic obstructive pulmonary disease. J Korean Med Sci. 2015;30(10):1459–65.
Wijkstra PJ, Van Altena R, Ten Vergert EM, Van Der Mark THW, Postma DS, Kraan J, et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax. 1994;49(5):468–72.
Kim V, Han MLK, Vance GB, Make BJ, Newell JD, Hokanson JE, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011;140(3):626–33.
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
